180 related articles for article (PubMed ID: 9527027)
1. Hyperleptinemia in patients with end-stage renal disease undergoing continuous ambulatory peritoneal dialysis.
Dagogo-Jack S; Ovalle F; Landt M; Gearing B; Coyne DW
Perit Dial Int; 1998; 18(1):34-40. PubMed ID: 9527027
[TBL] [Abstract][Full Text] [Related]
2. Serum leptin correlates with fat mass but not dietary energy intake in continuous ambulatory peritoneal dialysis patients.
Parry RG; Johnson DW; Carey DG; Hibbins M; Chang W; Purdie D; Rigby RJ
Perit Dial Int; 1998; 18(6):569-75. PubMed ID: 9932654
[TBL] [Abstract][Full Text] [Related]
3. The effect of continuous ambulatory peritoneal dialysis on change in serum leptin.
Kim DJ; Oh DJ; Kim B; Lim YH; Kang WH; Lee BH; Lee SK; Huh W; Kim SE; Lee MK; Kang SA; Oh HY
Perit Dial Int; 1999; 19 Suppl 2():S172-5. PubMed ID: 10406513
[TBL] [Abstract][Full Text] [Related]
4. Leptin in CAPD patients: serum concentrations and peritoneal loss.
Kagan A; Haran N; Leschinsky L; Shuali N; Rapoport J
Nephrol Dial Transplant; 1999 Feb; 14(2):400-5. PubMed ID: 10069196
[TBL] [Abstract][Full Text] [Related]
5. [Concentration of leptin in patients on hemodialysis and peritoneal dialysis].
Zbroch E; Małyszko J; Wołczyński S; Hryszko T; Myśliwiec M
Pol Arch Med Wewn; 1999 Jun; 101(6):503-8. PubMed ID: 10754736
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal insulin reduces plasma leptin concentration in diabetic patients on CAPD.
Nevalainen PI; Lahtela JT; Mustonen J; Pasternack A
Perit Dial Int; 2000; 20(1):27-32. PubMed ID: 10716580
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
8. Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients.
Tsujimoto Y; Shoji T; Tabata T; Morita A; Emoto M; Nishizawa Y; Morii H
Am J Kidney Dis; 1999 Nov; 34(5):832-8. PubMed ID: 10561138
[TBL] [Abstract][Full Text] [Related]
9. Leptin elimination in hyperleptinaemic peritoneal dialysis patients.
Landt M; Parvin CA; Dagogo-Jack S; Bryant B; Coyne DW
Nephrol Dial Transplant; 1999 Mar; 14(3):732-7. PubMed ID: 10193829
[TBL] [Abstract][Full Text] [Related]
10. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
11. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 in continuous ambulatory peritoneal dialysis and hemodialysis patients: a preliminary study.
Lightfoot BO; Caruana RJ
Perit Dial Int; 1993; 13(1):55-8. PubMed ID: 8443279
[TBL] [Abstract][Full Text] [Related]
13. Comparison of plasma amino acid concentrations in end-stage renal disease patients on hemodialysis and peritoneal dialysis.
Kim DH; Yang DH; Hong SY
Korean J Intern Med; 1998 Feb; 13(1):33-40. PubMed ID: 9538629
[TBL] [Abstract][Full Text] [Related]
14. Effects of oral glucose on intermediary metabolism in continuous ambulatory peritoneal dialysis patients versus healthy subjects.
Delarue J; Maingourd C; Couet C; Vidal S; Bagros P; Lamisse F
Perit Dial Int; 1998; 18(5):505-11. PubMed ID: 9848629
[TBL] [Abstract][Full Text] [Related]
15. The red blood cell deformability in patients suffering from end stage renal failure on hemodialysis or continuous ambulatory peritoneal dialysis.
Sotirakopoulos N; Tsitsios T; Stambolidou M; Athanasiou G; Peiou M; Kokkinou V; Mavromatidis K
Ren Fail; 2004 Mar; 26(2):179-83. PubMed ID: 15287203
[TBL] [Abstract][Full Text] [Related]
16. Three Versus 4 Daily Exchanges and Residual Kidney Function Decline in Incident CAPD Patients: A Randomized Controlled Trial.
Yan H; Fang W; Lin A; Cao L; Ni Z; Qian J
Am J Kidney Dis; 2017 Apr; 69(4):506-513. PubMed ID: 27751610
[TBL] [Abstract][Full Text] [Related]
17. Selected growth factors in peritoneal dialysis: their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport.
Stompór T; Zdzienicka A; Motyka M; Dembińska-Kieć A; Davies SJ; Sulowicz W
Perit Dial Int; 2002; 22(6):670-6. PubMed ID: 12556068
[TBL] [Abstract][Full Text] [Related]
18. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical characteristics of type 2 diabetic patients on continuous ambulatory peritoneal dialysis: relationships with insulin requirement.
Wong TY; Chan JC; Szeto CC; Leung CB; Li PK
Am J Kidney Dis; 1999 Sep; 34(3):514-20. PubMed ID: 10469863
[TBL] [Abstract][Full Text] [Related]
20. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
